Inventisbio Co., Ltd

This study is testing whether an investigational drug called D-2570 can improve skin symptoms in people with moderate-to-severe plaque psoriasis. About 75 participants will be randomly assigned to receive either D-2570 or a placebo for 12 weeks. The main goal is to see if the dru…

This study is testing an experimental pill called D-2570 to see if it can help control the disease activity in people with active systemic lupus erythematosus (SLE). About 120 participants will be randomly assigned to take either the new drug or a placebo pill once a day for near…

This study is testing an investigational oral medication called D-2570 for people with moderate to severe plaque psoriasis. It will compare the new drug's effectiveness and safety against a placebo (a dummy pill) and an existing approved medication. The goal is to see if D-2570 c…

This early-stage study aims to understand how a new drug called D-2570 is processed by the body. Eight healthy Chinese male volunteers will receive a single dose containing a tiny, safe amount of radioactive tracer. Researchers will carefully measure how the drug is broken down a…